Log in to your Inderes Free account to see all free content on this page.
Intervacc
1.14 SEK
-0.70 %
Less than 1K followers
IVACC
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Intervacc
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.5 | 4.1 | 11.8 | 4.6 | 7.0 | 5.4 | 3.1 | 20.1 |
| EBITDA | -17.9 | -14.0 | -58.8 | -8.9 | -14.0 | -10.3 | -31.7 | -64.9 |
| EBIT | -22.5 | -18.5 | -77.3 | -13.5 | -18.6 | -15.0 | -36.4 | -83.5 |
| EBIT-% | -889.7 % | -448.2 % | -655.5 % | -296.3 % | -265.5 % | -278.5 % | -1,164.8 % | -415.7 % |
| Profit before taxes | -22.2 | -18.1 | -75.5 | -13.2 | -17.8 | -14.3 | -35.6 | -80.8 |
| Net income | -22.2 | -18.1 | -75.5 | -13.2 | -17.8 | -14.3 | -35.6 | -80.8 |
Login required
This content is only available for logged in users